Bayer AG at UBS Global Healthcare Conference (Virtual) Transcript
Good morning, good afternoon, everybody. My name is Michael Leuchten. I'm one of the pharma analysts at UBS based in London. It's my pleasure today to introduce the Bayer team for today's -- for today's fireside chat, we have Jörgen Möller who's -- so Jörg Möller who's the Head of R&D at Bayer pharma, and we also have Jürgen Beunink with us from the IR team.
For participants on today's presentation, there is a way of submitting questions to me. I will see them on my screen. If you want to do that, please do so. We will have a start off with a list of questions that I will go through with Jörg, and then we'll see how far we can go and we can maybe fill some questions after.
So with that, thank you very much for joining us today.
Questions & Answers
Maybe to start off with, obviously, the COVID
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
